Cell and Gene Therapy Manufacturing Quality Control (QC) Market Forecast 2031: Ensuring Safety and Efficacy in Advanced Therapies | Transparency Market Research, Inc

Cell and Gene Therapy Manufacturing Quality Control (QC) Market Anticipated to achieve USD 2.8 Billion by 2031 | Fueled by Rapid Therapy Advancements and Stringent Regulatory Demands - Exclusive Report by Transparency Market Research, Inc.
04-02-2025 04:32 PM CET | Health & Medicine
Press release from: Transparency Market Research
Cell and Gene Therapy Manufacturing Quality Control (QC) Market
Cell and Gene Therapy Manufacturing Quality Control (QC) Market


Cell and gene therapies are transforming the treatment landscape for a wide range of diseases-from genetic disorders and cancers to autoimmune conditions. As these therapies transition from research to commercialization, ensuring their safety, efficacy, and consistency becomes paramount. In 2022, the global cell and gene therapy manufacturing QC market was valued at US$ 371.7 million and is projected to exceed US$ 2.8 billion by 2031, growing at a robust CAGR of 24.6% over the forecast period. The market's growth is driven by the need for stringent quality control measures that support regulatory compliance and foster the development of innovative therapeutic products.

Review significant findings and insights from our Report in this sample -

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85805

Analysts' Viewpoint

Industry experts emphasize that the surge in cell and gene therapy innovations is significantly boosting the demand for advanced quality control (QC) measures. The rapid development and adoption of these therapies have heightened the need to ensure product safety and consistency, prompting pharmaceutical and biotechnology companies to invest in cutting-edge analytical methods. Furthermore, strategic investments in research and development-as well as collaborations among industry players, research institutions, and regulatory bodies-are expected to further propel the market's growth. Nonetheless, high instrument costs and evolving regulatory challenges may pose potential hurdles.

Market Drivers

Expansion of Pharmaceutical & Biotechnology Industries

Therapeutic Breakthroughs: The success of therapies like CAR-T cell treatments in achieving durable responses in cancer patients has generated substantial interest and investment in cell and gene therapies.

Personalized Medicine: Tailored therapeutic approaches based on individual genetic profiles are driving demand for high-precision quality control measures.

Advancements in Analytical Technologies

Innovative Testing Techniques: Breakthroughs in next-generation sequencing, mass spectrometry, flow cytometry, and imaging technologies have revolutionized QC practices by offering enhanced sensitivity, resolution, and throughput.

Enhanced Product Consistency: Advanced analytical methods ensure the rigorous evaluation of therapeutic products, from raw materials to final formulations, thereby upholding safety and efficacy.

Critical Role of Consumables and Process Monitoring

Ongoing QC Requirements: Consumables such as reagents, test kits, and assay plates are indispensable for routine quality control testing, ensuring consistent monitoring throughout the manufacturing process.

Potency Testing: As a key parameter in assessing therapeutic effectiveness, potency testing remains a primary focus for regulatory bodies and market participants alike.

Stringent Regulatory Compliance

Regulatory Frameworks: Agencies like the FDA and EMA have established strict guidelines and expedited approval pathways that underscore the importance of quality control in the cell and gene therapy space.

Market Confidence: Adherence to these regulations not only ensures patient safety but also bolsters investor and stakeholder confidence in emerging therapies.

Consult our report for a thorough exploration of essential insights -

https://www.transparencymarketresearch.com/cell-and-gene-therapy-manufacturing-quality-control-qc-market.html

Product Segmentation

By Component

Equipment & Accessories

Consumables

Others

By Analytical Method

Sterility Testing

Purity Testing

Potency Testing

Identity Testing

Others (e.g., stability, viability)

By Process

Upstream Processes

Downstream Processes

Process Development

By End-user

Pharmaceutical & Biotechnology Companies

Contract Manufacturing Organizations

Regional Outlook

North America: Dominates the market with its robust pharmaceutical industry, advanced analytical laboratories, and stringent regulatory environment that drives high-quality production standards.

Europe: Benefits from state-of-the-art healthcare infrastructure and a strong focus on quality and compliance, supporting comprehensive QC testing.

Asia Pacific: Experiences rapid growth due to expanding R&D investments, increasing adoption of advanced therapies, and rising demand for innovative QC solutions amid a high disease burden.

Competitive Landscape
The global cell and gene therapy manufacturing QC market is highly fragmented, with numerous players competing to enhance product portfolios through technological innovation and strategic collaborations. Leading companies include:

bioMérieux SA

Bio-Rad Laboratories, Inc.

Bio-Techne Corporation

QIAGEN

Charles River Laboratories International, Inc.

Lonza Group AG

Merck KGaA

Intertek Group plc

Thermo Fisher Scientific, Inc.

Eurofins Scientific S.E.

Hoffmann-La Roche Ltd.
Recent initiatives, such as Bio-Techne Corporation's participation in the Cell and Gene Therapy Catapult Process Analytical Technology consortium and Bio-Rad Laboratories' launch of innovative ddPCR-based products, highlight the industry's commitment to advancing QC capabilities.

Future Outlook
As the cell and gene therapy landscape evolves, the demand for sophisticated quality control measures is set to soar. Continued technological advancements, coupled with increased R&D investments and strategic partnerships, will be crucial in driving market growth. Manufacturers are expected to focus on developing cost-effective, high-performance QC solutions that address the specific needs of this rapidly growing therapeutic segment. With ongoing regulatory support and market expansion, the industry is well-positioned to meet the challenges of ensuring consistent and safe therapeutic outcomes.

Want to know more? Get in touch now. -https://www.transparencymarketresearch.com/contact-us.html

FAQs

Q1: What is cell and gene therapy manufacturing quality control (QC)?
A: It is a set of processes and analytical methods used to ensure the safety, efficacy, and consistency of cell and gene therapies throughout their manufacturing lifecycle.

Q2: What factors are driving market growth?
A: Key drivers include the rapid expansion of pharmaceutical and biotechnology industries, technological advancements in analytical methods, and stringent regulatory requirements for QC.

Q3: What is the projected market value by 2031?
A: The market is expected to exceed US$ 2.8 billion by 2031, growing at a CAGR of 24.6% from 2023 to 2031.

Q4: Which regions are leading the market?
A: North America currently dominates, with Europe and Asia Pacific also showing strong growth potential.

Q5: Who are the key players in this market?
A: Major players include bioMérieux SA, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, QIAGEN, Charles River Laboratories International, Inc., and Thermo Fisher Scientific, Inc., among others.

Explore Latest Research Reports by Transparency Market Research:

Cardiac Pacemakers Market - https://www.transparencymarketresearch.com/cardiac-pacemakers-market.html

Intracranial Stents Market - https://www.transparencymarketresearch.com/intracranial-stents-market.html

Injection Pen Market - https://www.transparencymarketresearch.com/injection-pen-market.html

Linear Particle Accelerators Market - https://www.transparencymarketresearch.com/linear-particle-accelerators-market.html

Voice Prosthesis Devices Market - https://www.transparencymarketresearch.com/voice-prosthesis-devices-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.